Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3792 3796
This examiner grants 60% of resolved cases
Daniel Tehrani works in Tech Center 3700 and Art Unit 3792. The examiner has 62 resolved cases and an allowance rate of 59.7 percent. The interview lift is 42.9 percent, which is a high increase in the likelihood of allowance. This suggests that interviews are a critical component of a successful strategy with this examiner. Practitioners should prioritize verbal communication to address rejections and move toward a grant.
The median days to allowance is 1347. This duration for the 62 cases resolved suggests that the process takes time. The 59.7 percent allowance rate provides a baseline for success, while the 42.9 percent interview lift offers a clear path to improving those odds. The 1347-day median pendency provides a specific timeline for applications in Art Unit 3792. With 62 cases handled, the examiner has a documented record in Tech Center 3700. These metrics help applicants plan their prosecution effectively.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18934118 | OPTIMIZATION OF DBS PROGRAM USING A PRESPECIFIED SELECTION OF CONTACTS | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18915543 | PEDIATRIC DETECTION AND ALL AGE GROUPS CLASSIFICATION FROM ECG | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 19030444 | WEARABLE, ERGONOMIC NEUROSTIMULATION SYSTEM | Non-Final OA | Cala Health, Inc. |
| 19083634 | COMPUTERIZED ECG INTERPRETATION VISUALIZATION | Non-Final OA | Welch Allyn, Inc. |
| 18904366 | HEART FAILURE READMISSION | Non-Final OA | Cardiac Pacemakers, Inc. |
| 17617233 | INTRAOPERATIVE 'NON-LIFTING' PERIPHERAL NERVE ACTION POTENTIAL RECORDING | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18951176 | AMPLITUDE MODULATION FOR TUMOR TREATING FIELDS | Non-Final OA | Novocure GmbH |
| 18080026 | TRANSDUCER ARRAY WITH ADHESIVE LAYER SHAPED TO REDUCE SKIN IRRITATION | Final Rejection | Novocure GmbH |
| 18062161 | COMPACT DC SYSTEM FOR DELIVERING A SQUARE WAVE AC SIGNAL | Non-Final OA | Novocure GmbH |
| 18071933 | Devices, Systems, And Methods For Applying Tumor-Treating Fields | Final Rejection | NOVOCURE GMBH |
| 17987787 | Electrode Assembly with Non-Hydrogel Conductive Adhesive Layer and Methods of Applying Tumor Treating Fields Using Same | Final Rejection | Novocure GmbH |
| 17886382 | TRANSDUCER APPARATUSES WITH ELECTRODE ARRAY SHAPED TO REDUCE EDGE EFFECT IN DELIVERING TUMOR TREATING FIELDS TO A SUBJECT'S BODY | Final Rejection | Novocure GmbH |
| 17698457 | TRANSDUCER APPARATUSES FOR DELIVERING TUMOR TREATING FIELDS TO A SUBJECT'S BODY | Final Rejection | Novocure GmbH |
| 18877731 | NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITION | Final Rejection | RESHAPE LIFESCIENCES, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy